Curebiotech, Inc.
Albertson, NY · Biotech · Private
CB101, an intratumoral controlled-release formulation of resiquimod (a toll-like receptor 7/8 agonist) using a polymer matrix for localized cancer immunotherapy
- Grants
- $2.5M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Novel injectable resiquimod formulation for treatment of metastatic cancers | $202,854 | |
| Federal grant | Department of Health and Human Services · Phase II · Intratumoral immunotherapy with formulated resiquimod for metastatic melanoma | $1,024,973 | |
| Federal grant | Department of Health and Human Services · Phase II · Intratumoral immunotherapy with formulated resiquimod for metastatic melanoma | $974,959 | |
| Federal grant | Department of Health and Human Services · Phase I · Combination of CB101 and radiation therapy in head and neck squamous cell carcinoma | $250,876 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1366 | WEATHERWAX BIOTECHNOLOGIES CORPORATION | — | — |
| 1367 | NANO BIOTHERAPEUTICS INC | — | — |
| 1368 | ARTUS THERAPEUTICS INC. | — | — |
| 1369 | Curebiotech, Inc. | — | — |
| 1370 | BOUND THERAPEUTICS LLC | — | — |
| 1371 | BioHybrid Solutions LLC | — | — |
| 1372 | VERACHEM LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.